Back to top
more

Alcon (ALC)

(Delayed Data from NYSE)

$79.00 USD

79.00
1,163,755

-0.61 (-0.77%)

Updated Apr 17, 2024 04:00 PM ET

After-Market: $78.99 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why Investors Should Buy Alcon (ALC) Stock Right Now

by Zacks Equity Research

Strength in the Surgical and Vision Care businesses bodes well for Alcon (ALC).

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The Zacks Analyst Blog Highlights Booking Holdings, Mitsubishi UFJ Financial, Micron Technology, American Electric Power and Alcon

by Zacks Equity Research

Booking Holdings, Mitsubishi UFJ Financial, Micron Technology, American Electric Power and Alcon are part of the Zacks Analyst Blog.

Sheraz Mian headshot

Top Analyst Reports for Booking Holdings, Mitsubishi UFJ & Micron Technology

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Booking Holdings Inc. (BKNG), Mitsubishi UFJ Financial Group, Inc. (MUFG) and Micron Technology, Inc. (MU).

Alcon's (ALC) New Launch Strengthens IOL Innovation Leadership

by Zacks Equity Research

Alcon's (ALC) Clareon platform is available in India in two PCIOL technologies, PanOptix and Vivity.

Alcon's (ALC) Vivity EDOF IOL Achieves One Million Milestone

by Zacks Equity Research

Alcon's (ALC) Vivity features the first-of-its-kind, patented wavefront-shaping technology, which simplifies presbyopia correction for surgeons and patients.

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Alcon (ALC) Q4 Earnings Beat Estimates, Margins Expand

by Zacks Equity Research

Alcon (ALC) delivers impressive performance across its franchises in the fourth quarter of 2023.

Alcon (ALC) Reports Q4 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Alcon (ALC) Faces Rising Expenses, Tough Competitive Scenario

by Zacks Equity Research

In the surgical business, Alcon (ALC) faces a mix of competitors, ranging from large manufacturers with multiple business lines to small manufacturers.

Wall Street's Insights Into Key Metrics Ahead of Alcon (ALC) Q4 Earnings

by Zacks Equity Research

Beyond analysts' top -and-bottom-line estimates for Alcon (ALC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

Alcon (ALC) Business Hurt by Macroeconomic Woes, Competition

by Zacks Equity Research

In the surgical business, Alcon (ALC) faces a mix of competitors, ranging from large manufacturers with multiple business lines to small manufacturers.

ALC or IDXX: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ALC vs. IDXX: Which Stock Is the Better Value Option?

Company News for Nov 16, 2023

by Zacks Equity Research

Companies In The News Are: ALC, XPEV, OLK, AAP.

Alcon (ALC) Q3 Earnings Miss Estimates, Margins Increase

by Zacks Equity Research

Alcon (ALC) Q3 revenues increase year over year, driven by strength in Surgical and Vision Care segments.

Alcon (ALC) Reports Q3 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

While the top- and bottom-line numbers for Alcon (ALC) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Here's Why Investors Should Buy Alcon (ALC) Stock Right Now

by Zacks Equity Research

Investors continue to be optimistic about Alcon (ALC), backed by a competitive product portfolio and strong commercial execution.

Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Alcon (ALC) and Alpine Immune Sciences, Inc. (ALPN) have performed compared to their sector so far this year.

Alcon (ALC) Unveils New Progress in Presbyopia Correcting IOLs

by Zacks Equity Research

Alcon's (ALC) Clareon Vivity IOL highlights proven results and high levels of patient satisfaction. It will offer a similar halo profile compared with a monofocal IOL.

Zacks Industry Outlook Highlights Alcon, STERIS and Inari Medical

by Zacks Equity Research

Alcon, STERIS and Inari Medical are part of the Zacks Industry Outlook article.

Urmimala Biswas headshot

3 Medical Instruments Stocks Countering Industry-Wide Headwinds

by Urmimala Biswas

The Zacks Medical - Instruments industry is being affected by ongoing inflation and a tightening monetary policy. However, the rising demand for digital health offers some respite. ALC, STE and NARI are poised to brave the challenges.

Are Medical Stocks Lagging Alcon (ALC) This Year?

by Zacks Equity Research

Here is how Alcon (ALC) and Alpine Immune Sciences, Inc. (ALPN) have performed compared to their sector so far this year.

Intuitive Surgical (ISRG) Q3 Earnings Beat, Procedures Robust

by Zacks Equity Research

Intuitive Surgical's (ISRG) third-quarter results reflect healthy demand for procedures, partially offset by lower system sales. Higher pricing boosted procedure sales.

Philips (PHG) Aids Clinicians With New Monitoring Solution

by Zacks Equity Research

Philips (PHG) launches Visual Patient Avatar to help anesthesiologists with situational awareness in operating rooms, boosting their clinical confidence.

Alcon (ALC) Stock Up 9.7% YTD: Will the Rally Continue?

by Zacks Equity Research

Alcon (ALC) continues gaining from the company's diverse portfolio, incremental innovation, and new product launches.